{
  "$schema": "folio-library-document/v1",
  "id": "10665-69654",
  "title": "Preparación de las introducción de las vacunas contra el virus del papiloma humano : orientaciones normativas y programáticas para los países",
  "variant": "pdf",
  "pages": 30,
  "tocSource": "undetermined",
  "tocMethod": "contents",
  "toc": [],
  "sections": [
    {
      "id": "page-001",
      "number": null,
      "title": "Page 1",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 1,
      "labelStart": "I",
      "labelEnd": "I",
      "words": 20,
      "summary": {
        "text": "The cover page of the Spanish edition of WHO's guidance for countries on preparing to introduce human papillomavirus vaccines.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Preparación de la introducción de las vacunas contra el virus del papiloma humano Orientaciones normativas y programáticas para los países",
      "extractCut": false,
      "blocks": [
        "library/10665-69654/blocks/prose-page-001"
      ]
    },
    {
      "id": "page-002",
      "number": null,
      "title": "Page 2",
      "level": 1,
      "pageStart": 2,
      "pageEnd": 2,
      "labelStart": "II",
      "labelEnd": "II",
      "words": 20,
      "summary": {
        "text": "The title page of the Spanish edition of WHO's policy and programme guidance on preparing to introduce HPV vaccines.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Preparación de la introducción de las vacunas contra el virus del papiloma humano. Orientaciones normativas y programáticas para los países",
      "extractCut": false,
      "blocks": [
        "library/10665-69654/blocks/prose-page-002"
      ]
    },
    {
      "id": "page-003",
      "number": null,
      "title": "Page 3",
      "level": 1,
      "pageStart": 3,
      "pageEnd": 3,
      "labelStart": "ii",
      "labelEnd": "ii",
      "words": 353,
      "summary": {
        "text": "The copyright page of the Spanish edition, © World Health Organization 2006, with standard WHO disclaimers; it still contains draft placeholders such as a bracketed note to name the expert group and 'Printed in …'.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "organización mundial",
          "heading": false
        },
        {
          "term": "las denominaciones",
          "heading": false
        },
        {
          "term": "las publicaciones",
          "heading": false
        },
        {
          "term": "correo electrónico",
          "heading": false
        },
        {
          "term": "esta publicación",
          "heading": false
        },
        {
          "term": "salud",
          "heading": false
        },
        {
          "term": "ediciones",
          "heading": false
        },
        {
          "term": "fronteras",
          "heading": false
        }
      ],
      "extract": "Preparación de la introducción de las vacunas contra el virus del papiloma humano. Orientaciones normativas y programáticas para los países © Organización Mundial de la Salud, 2006 Se reservan todos los derechos. Las publicaciones de la Organización Mundial de la Salud pueden solicitarse a Ediciones de la OMS, Organización Mundial de la Salud, 20 Avenue Appia, 1211 Ginebra 27, Suiza (tel.: +41 22 791 3264; fax: +41",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-003"
      ]
    },
    {
      "id": "page-004",
      "number": null,
      "title": "Page 4",
      "level": 1,
      "pageStart": 4,
      "pageEnd": 4,
      "labelStart": "iii",
      "labelEnd": "iii",
      "words": 94,
      "summary": {
        "text": "The table of contents of the Spanish edition, listing sections from cervical cancer and HPV infection through vaccines, target groups, communication, service delivery, monitoring, stewardship and financing; most page numbers are placeholders ('xx').",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vacunas contra",
          "heading": false
        },
        {
          "term": "grupos diana",
          "heading": false
        },
        {
          "term": "vph",
          "heading": false
        }
      ],
      "extract": "Introducción 1 Cáncer de cuello de útero e infecciones por VPH 2 Vacunas contra el VPH 3 Grupos diana de la inmunización contra el VPH xx Aspectos inhabituales de las vacunas contra el VPH xx Una oportunidad única xx Un producto oneroso xx Problemática de la introducción xx Nuevas formas de colaboración xx Sensibilización, información y comunicación xx Actividades xx Prestación de servicios xx Llegar a los grupos",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-004"
      ]
    },
    {
      "id": "page-005",
      "number": null,
      "title": "Page 5",
      "level": 1,
      "pageStart": 5,
      "pageEnd": 5,
      "labelStart": "iv",
      "labelEnd": "iv",
      "words": 325,
      "summary": {
        "text": "Acknowledgements for the Spanish edition, explaining that the document draws on a technical consultation on sexual and reproductive health and HPV vaccination programmes held in Montreux, Switzerland, on 14–16 March 2006, and listing the participating experts and WHO departments.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "felicity cutts",
          "heading": false
        },
        {
          "term": "dale huntington",
          "heading": false
        },
        {
          "term": "del unfpa",
          "heading": false
        },
        {
          "term": "nathalie broutet",
          "heading": false
        },
        {
          "term": "peter hall",
          "heading": false
        },
        {
          "term": "los siguientes",
          "heading": false
        },
        {
          "term": "departamento",
          "heading": false
        },
        {
          "term": "reunión",
          "heading": false
        }
      ],
      "extract": "Este documento se basa en los resultados de las deliberaciones de una reunión consultiva técnica titulada “Programas de salud sexual y reproductiva y de vacunación contra el VPH”, que tuvo lugar del 14 al 16 de marzo de 2006 en Montreux, Suiza. La reunión contó con la participación de los siguientes expertos: Rebecca Affolder, Sebolelo Amos, Gayane Avakyan, Miranda Balkin, Emily Bass, Robin Biellik, Paul Blumen-",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-005"
      ]
    },
    {
      "id": "page-006",
      "number": null,
      "title": "Page 6",
      "level": 1,
      "pageStart": 6,
      "pageEnd": 6,
      "labelStart": "1",
      "labelEnd": "1",
      "words": 516,
      "summary": {
        "text": "Introduces the guidance, in Spanish, explaining that it comes from a UNFPA–WHO consultation and is meant to inform those working in sexual and reproductive health, immunization, adolescent health and cancer control about HPV vaccine introduction. It describes the burden of cervical cancer and notes that wide screening coverage has greatly reduced deaths in high-income countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "cuello uterino",
          "heading": false
        },
        {
          "term": "por vph",
          "heading": false
        },
        {
          "term": "cáncer cervicouterino",
          "heading": false
        },
        {
          "term": "las infecciones",
          "heading": false
        },
        {
          "term": "detección precoz",
          "heading": false
        },
        {
          "term": "las mujeres",
          "heading": false
        },
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "del papiloma",
          "heading": false
        }
      ],
      "extract": "Este documento de orientación se basa en los resultados de las deliberaciones de una reunión consultiva técnica titulada “Programas de Salud Sexual y Reproductiva y de Vacunación contra el VPH”, organizada conjuntamente por el UNFPA y la OMS, que tuvo lugar en marzo de 2006 en Montreux, Suiza. Tiene por objeto informar a los interesados directos de los numerosos programas de salud sexual y reproductiva,",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-006"
      ]
    },
    {
      "id": "page-007",
      "number": null,
      "title": "Page 7",
      "level": 1,
      "pageStart": 7,
      "pageEnd": 7,
      "labelStart": "2",
      "labelEnd": "2",
      "words": 204,
      "summary": {
        "text": "Summarizes, in Spanish, World Health Assembly resolution WHA58.22 on cancer prevention and control, which stresses the importance of cervical cancer control, and includes a figure on HPV infection and cervical cancer by women's age.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "cáncer cervicouterino",
          "heading": false
        },
        {
          "term": "del cáncer",
          "heading": false
        },
        {
          "term": "preven ción",
          "heading": false
        },
        {
          "term": "asamblea mundial",
          "heading": false
        },
        {
          "term": "control del",
          "heading": false
        },
        {
          "term": "resolución",
          "heading": false
        },
        {
          "term": "cación",
          "heading": false
        }
      ],
      "extract": "Resolución de la Asamblea Mundial de la Salud sobre la preven- ción y el control del cáncer En el marco de la intensiﬁ cación de las actividades de la OMS contra el cáncer, los Esta- dos Miembros de la Organización adoptaron la Resolución WHA58.22 sobre la preven- ción y el control de esa enfermedad en el curso de la 58ª Asamblea Mundial de la Salud, celebrada en 2005. En esa resolución se destaca que el control del",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-007"
      ]
    },
    {
      "id": "page-008",
      "number": null,
      "title": "Page 8",
      "level": 1,
      "pageStart": 8,
      "pageEnd": 8,
      "labelStart": "3",
      "labelEnd": "3",
      "words": 570,
      "summary": {
        "text": "Describes, in Spanish, the two prophylactic HPV vaccines, which trials showed to be highly effective in women aged 16–24 not previously exposed to the virus, and notes that HPV types 16 and 18 cause 70% of cervical cancers. It reports the licensing status of Gardasil and the expected approval of Cervarix in 2006.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "contra los",
          "heading": false
        },
        {
          "term": "contra las",
          "heading": false
        },
        {
          "term": "del vph",
          "heading": false
        },
        {
          "term": "las lesiones",
          "heading": false
        },
        {
          "term": "vacunas contra",
          "heading": false
        },
        {
          "term": "los estudios",
          "heading": false
        },
        {
          "term": "del cáncer",
          "heading": false
        },
        {
          "term": "los genotipos",
          "heading": false
        }
      ],
      "extract": "carecen de capacidad infectiva. Estudios sobre la actividad biológica de dos vacunas proﬁ lácticas contra la infección persistente por el virus del papiloma humano y las lesiones cervicales conexas pusieron de maniﬁ esto su excelente eﬁ ciencia en mujeres sin antecedentes previos (es decir, que nunca habían estado expuestas al virus), de 16 a 24 años de edad. Los tipos 16 y 18 del VPH, que provocan el 70% de los",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-008"
      ]
    },
    {
      "id": "page-009",
      "number": null,
      "title": "Page 9",
      "level": 1,
      "pageStart": 9,
      "pageEnd": 9,
      "labelStart": "4",
      "labelEnd": "4",
      "words": 246,
      "summary": {
        "text": "Notes, in Spanish, that follow-up of phase III trial participants continues to answer open questions relevant to vaccination programmes, such as duration of protection, and includes a figure on HPV types in women with cancer by region.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ambas vacunas",
          "heading": false
        },
        {
          "term": "vph",
          "heading": false
        },
        {
          "term": "inmunogenicidad",
          "heading": false
        },
        {
          "term": "tolerancia",
          "heading": false
        },
        {
          "term": "los",
          "heading": false
        },
        {
          "term": "administrar",
          "heading": false
        },
        {
          "term": "inmunización",
          "heading": false
        },
        {
          "term": "por",
          "heading": false
        }
      ],
      "extract": "Actualmente se prosigue, en numerosos centros, la labor de seguimiento de las participantes en los extensos estudios clínicos de fase III y se están estableciendo correlaciones entre los resultados obtenidos sobre la immunogenicidad de ambas vacunas candidatas y su tolerancia a ﬁ n de zanjar ciertas cuestiones pendientes. Estas últimas incluyen algunos asuntos de particular interés para los programas y estrategias",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-009"
      ]
    },
    {
      "id": "page-010",
      "number": null,
      "title": "Page 10",
      "level": 1,
      "pageStart": 10,
      "pageEnd": 10,
      "labelStart": "5",
      "labelEnd": "5",
      "words": 452,
      "summary": {
        "text": "Explains, in Spanish, that HPV vaccines are expected to be licensed first for girls and women aged 9–26, with stronger immune responses in younger girls. It notes that effects in women over 25 or already infected with types 16 or 18 still need study and that cost-effectiveness for these groups is unknown.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "las mujeres",
          "heading": false
        },
        {
          "term": "mujeres embarazadas",
          "heading": false
        },
        {
          "term": "los grupos",
          "heading": false
        },
        {
          "term": "los hombres",
          "heading": false
        },
        {
          "term": "los cánceres",
          "heading": false
        },
        {
          "term": "los estudios",
          "heading": false
        },
        {
          "term": "las vacunas",
          "heading": false
        },
        {
          "term": "según los",
          "heading": false
        }
      ],
      "extract": "Según las indicaciones disponibles en la actualidad, la comercialización de las vacunas contra el VPH se autorizará inicialmente para su administración a niñas y mujeres de 9 a 26 años de edad. Según los estudios realizados, se ha comprobado que la vacunación provoca porcentajes de seroconversión elevados en todos los grupos de edad estudiados, pero la comparación de los estudios de inmunogenicidad de ambas vacunas",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-010"
      ]
    },
    {
      "id": "page-011",
      "number": null,
      "title": "Page 11",
      "level": 1,
      "pageStart": 11,
      "pageEnd": 11,
      "labelStart": "6",
      "labelEnd": "6",
      "words": 428,
      "summary": {
        "text": "Links HPV vaccination, in Spanish, to WHO's 2004 Global Reproductive Health Strategy and its core aspects of sexual and reproductive health. It notes that, unlike vaccines such as rubella or tetanus, HPV vaccines will draw immunization programmes into sensitive issues of adolescent sexuality.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "las vacunas",
          "heading": false
        },
        {
          "term": "salud reproductiva",
          "heading": false
        },
        {
          "term": "vacunas contra",
          "heading": false
        },
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "reproductiva sexual",
          "heading": false
        },
        {
          "term": "las infecciones",
          "heading": false
        },
        {
          "term": "las características",
          "heading": false
        },
        {
          "term": "cáncer cervicouterino",
          "heading": false
        }
      ],
      "extract": "En la Estrategia Mundial de Salud Reproductiva (Salud reproductiva: estrategia para acelerar el avance hacia el logro de los objetivos y metas internacionales de desarrollo, Ginebra, Organización Mundial de la Salud, 2005) adoptada por los Estados Miembros de la OMS en 2004 (Resolución WHA57.12 de la Asamblea Mundial de la Salud) se deter- minaron los cinco aspectos fundamentales de la salud reproductiva y sexual, a",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-011"
      ]
    },
    {
      "id": "page-012",
      "number": null,
      "title": "Page 12",
      "level": 1,
      "pageStart": 12,
      "pageEnd": 12,
      "labelStart": "7",
      "labelEnd": "7",
      "words": 124,
      "summary": {
        "text": "A footnote page, in Spanish, explaining that hepatitis B vaccine was added to immunization programmes without links to cancer control because infection mainly occurs in early childhood, and noting the difficulty of extending immunization beyond infants to older groups.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "los niños",
          "heading": false
        },
        {
          "term": "vacuna contra",
          "heading": false
        },
        {
          "term": "las infecciones",
          "heading": false
        },
        {
          "term": "mayoría",
          "heading": false
        },
        {
          "term": "cáncer",
          "heading": false
        }
      ],
      "extract": "2 Si bien actualmente la mayoría de los PAI incluye la vacuna contra la hepatitis B, que protege contra el cáncer de hígado conexo, la vacunación de los niños se debe a que, en los países en desarrollo, la mayoría de las infecciones se registra en la pequeña infancia. Por consiguiente, para introducir la vacuna contra la hepatitis B no fue preciso trabajar en colaboración directa con los programas de control del",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-012"
      ]
    },
    {
      "id": "page-013",
      "number": null,
      "title": "Page 13",
      "level": 1,
      "pageStart": 13,
      "pageEnd": 13,
      "labelStart": "8",
      "labelEnd": "8",
      "words": 359,
      "summary": {
        "text": "Summarizes, in Spanish, the UNICEF–WHO Global Immunization Vision and Strategy, which aims by 2015 for immunization to be a high priority and equitably available to all ages. It notes that efforts to prevent and control cervical cancer have so far been limited.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "estrategia mundial",
          "heading": false
        },
        {
          "term": "inmuni zación",
          "heading": false
        },
        {
          "term": "visión estrategia",
          "heading": false
        },
        {
          "term": "asamblea mundial",
          "heading": false
        },
        {
          "term": "del cáncer",
          "heading": false
        },
        {
          "term": "las actividades",
          "heading": false
        },
        {
          "term": "las vacunas",
          "heading": false
        },
        {
          "term": "inmunización",
          "heading": false
        }
      ],
      "extract": "Visión y Estrategia Mundial de Inmunización del UNICEF y la OMS La 58ª Asamblea Mundial de la Salud aprobó la Visión y Estrategia Mundial de Inmuni- zación, preparada por el UNICEF y la OMS. Se trata de una nueva visión de la inmuni- zación dirigida a que en el mundo de 2015: • se asigne alta prioridad a la inmunización • todo niño, adolescente y adulto pueda acceder en pie de igualdad a la inmunización en el marco",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-013"
      ]
    },
    {
      "id": "page-014",
      "number": null,
      "title": "Page 14",
      "level": 1,
      "pageStart": 14,
      "pageEnd": 14,
      "labelStart": "9",
      "labelEnd": "9",
      "words": 509,
      "summary": {
        "text": "Argues, in Spanish, that experience introducing HPV vaccines could serve as a model for a future HIV vaccine and is relevant to the HIV community. It discusses the unique opportunity and high cost of HPV vaccines, warning that private-sector introduction could favour better-off groups and high- and middle-income countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vacunas contra",
          "heading": false
        },
        {
          "term": "las vacunas",
          "heading": false
        },
        {
          "term": "las actividades",
          "heading": false
        },
        {
          "term": "para que",
          "heading": false
        },
        {
          "term": "los países",
          "heading": false
        },
        {
          "term": "mundial para",
          "heading": false
        },
        {
          "term": "cáncer cervicouterino",
          "heading": false
        },
        {
          "term": "vph",
          "heading": false
        }
      ],
      "extract": "La experiencia que se adquirirá con la introducción de las vacunas contra el VPH podría servir de modelo para la eventual vacuna contra el virus de inmunodeﬁ ciencia humana (VIH); además, la prevención y el tratamiento del cáncer cervicouterino en las mujeres inmunodeﬁ cientes también resultarán de interés para la comunidad dedicada al VIH. De ese modo, se atenderán las recomendaciones del Llamamiento de Nueva York",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-014"
      ]
    },
    {
      "id": "page-015",
      "number": null,
      "title": "Page 15",
      "level": 1,
      "pageStart": 15,
      "pageEnd": 15,
      "labelStart": "10",
      "labelEnd": "10",
      "words": 425,
      "summary": {
        "text": "Warns, in Spanish, that uneven introduction could widen health inequities, calling for strong public–private partnerships. It discusses how vaccination strategy must reflect each country's circumstances and the possible delays between licensing, affordable pricing and adequate supply in developing countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "del cáncer",
          "heading": false
        },
        {
          "term": "cáncer cervicouterino",
          "heading": false
        },
        {
          "term": "los países",
          "heading": false
        },
        {
          "term": "vacunación contra",
          "heading": false
        },
        {
          "term": "entre los",
          "heading": false
        },
        {
          "term": "vacunas contra",
          "heading": false
        },
        {
          "term": "para adolescentes",
          "heading": false
        }
      ],
      "extract": "del sector público. Por consiguiente, se correría el riesgo de que su introducción incrementara las desigualdades entre la población en materia de salud. En todos los contextos será necesario crear fuertes alianzas entre los sectores público y privado para evitarlo. Problemática de la introducción La estrategia de vacunación y la promoción de las vacunas contra el VPH deberán basarse en las circunstancias",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-015"
      ]
    },
    {
      "id": "page-016",
      "number": null,
      "title": "Page 16",
      "level": 1,
      "pageStart": 16,
      "pageEnd": 16,
      "labelStart": "11",
      "labelEnd": "11",
      "words": 481,
      "summary": {
        "text": "Discusses, in Spanish, the challenges of designing balanced advocacy, information and communication on HPV vaccination for varied audiences. It lists key facts to convey, such as that most HPV infections cause no symptoms and can be passed on unknowingly.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "las diﬁ",
          "heading": false
        },
        {
          "term": "cáncer cervicouterino",
          "heading": false
        },
        {
          "term": "las vacunas",
          "heading": false
        },
        {
          "term": "diﬁ cultades",
          "heading": false
        },
        {
          "term": "los casos",
          "heading": false
        },
        {
          "term": "sexual reproductiva",
          "heading": false
        },
        {
          "term": "vía sexual",
          "heading": false
        },
        {
          "term": "por vía",
          "heading": false
        }
      ],
      "extract": "La preparación de programas de sensibilización, información y comunicación sobre la vacunación contra el VPH, dirigidos a interesados directos y públicos muy distintos, comprende problemáticas y oportunidades especíﬁ cas. Una de las diﬁ cultades consiste en preparar un programa ponderado e informativo de educación del público y comunicación sobre el VPH, el cáncer cervicouterino y otros tumores malignos y",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-016"
      ]
    },
    {
      "id": "page-017",
      "number": null,
      "title": "Page 17",
      "level": 1,
      "pageStart": 17,
      "pageEnd": 17,
      "labelStart": "12",
      "labelEnd": "12",
      "words": 474,
      "summary": {
        "text": "Continues the key messages, in Spanish, noting that the vaccines are highly effective in unexposed women aged 16–26 and expected to prevent up to 70% of cervical cancers, best given before first sexual contact. It stresses that national data on cervical cancer burden, HPV types and age at first sex should guide policy.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "protegen contra",
          "heading": false
        },
        {
          "term": "vacunas contra",
          "heading": false
        },
        {
          "term": "las mujeres",
          "heading": false
        },
        {
          "term": "las que",
          "heading": false
        },
        {
          "term": "los servicios",
          "heading": false
        },
        {
          "term": "los tipos",
          "heading": false
        },
        {
          "term": "todos los",
          "heading": false
        },
        {
          "term": "también será",
          "heading": false
        }
      ],
      "extract": "• Las vacunas proﬁ lácticas contra el VPH son sumamente eﬁ caces en las mujeres de 16 a 26 años que nunca han estado expuestas a ese virus y se espera que prevengan hasta un 70% de cánceres cervicouterinos en las mujeres vacunadas. • Probablemente, el efecto máximo de las vacunas contra el VPH se obtendrá administrándolas antes de la primera relación sexual. • Ambas vacunas contra el VPH también pueden proteger",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-017"
      ]
    },
    {
      "id": "page-018",
      "number": null,
      "title": "Page 18",
      "level": 1,
      "pageStart": 18,
      "pageEnd": 18,
      "labelStart": "13",
      "labelEnd": "13",
      "words": 504,
      "summary": {
        "text": "Sets out, in Spanish, the elements of a communication strategy on cervical cancer control and HPV vaccines aimed at decision makers, health professionals, women and communities, timed to national decisions. It lists what information to give target groups, such as indications, safety and side-effects.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "las razones",
          "heading": false
        },
        {
          "term": "los mensajes",
          "heading": false
        },
        {
          "term": "las vacunas",
          "heading": false
        },
        {
          "term": "los motivos",
          "heading": false
        },
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "con los",
          "heading": false
        },
        {
          "term": "por las",
          "heading": false
        },
        {
          "term": "del cáncer",
          "heading": false
        }
      ],
      "extract": "• Una estrategia de comunicación sobre el control del cáncer cervical en general, y las vacunas contra el VPH en particular, que debería estar dirigida a los interesados directos y los responsables de la adopción de decisiones clave, así como a los profesionales de la salud, las mujeres y la comunidad. Esos mensajes deberían coincidir con los procesos nacionales de adopción de decisiones y las etapas del programa de",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-018"
      ]
    },
    {
      "id": "page-019",
      "number": null,
      "title": "Page 19",
      "level": 1,
      "pageStart": 19,
      "pageEnd": 19,
      "labelStart": "14",
      "labelEnd": "14",
      "words": 262,
      "summary": {
        "text": "Continues the communication guidance, in Spanish, stressing that vaccination does not imply stigma or that a girl is sexually active and setting out what is still unknown, such as use in women with HIV or pregnant women. It suggests linking messages to existing adolescent programmes such as school-based sexual health, nutrition, tobacco and HIV prevention education.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vacunas contra",
          "heading": false
        },
        {
          "term": "como los",
          "heading": false
        },
        {
          "term": "las vacunas",
          "heading": false
        },
        {
          "term": "los grupos",
          "heading": false
        },
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "vida sexual",
          "heading": false
        },
        {
          "term": "vph",
          "heading": false
        },
        {
          "term": "mujeres",
          "heading": false
        }
      ],
      "extract": "el VPH a determinadas poblaciones diana; la explicación de que su vacunación no implica su estigmatización, ni la presunción de que ha iniciado la vida sexual; los aspectos de la vacuna que aún se desconocen, como su administración a mujeres infectadas por el VIH, mujeres embarazadas y mujeres que no han recibido un tratamiento completo de inmunización; la importancia de la vacuna contra el VPH, tanto en términos",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-019"
      ]
    },
    {
      "id": "page-020",
      "number": null,
      "title": "Page 20",
      "level": 1,
      "pageStart": 20,
      "pageEnd": 20,
      "labelStart": "15",
      "labelEnd": "15",
      "words": 515,
      "summary": {
        "text": "Discusses, in Spanish, reaching target groups, with a likely licensed age range of 9–26 divided into a priority group of girls aged 9–13 and a catch-up group. It weighs delivery through schools, health services and community programmes, including challenges in extending the cold chain to adolescent programmes.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "las escuelas",
          "heading": false
        },
        {
          "term": "vph los",
          "heading": false
        },
        {
          "term": "los adolescentes",
          "heading": false
        },
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "llegar los",
          "heading": false
        },
        {
          "term": "las vacunas",
          "heading": false
        },
        {
          "term": "para las",
          "heading": false
        },
        {
          "term": "las comunidades",
          "heading": false
        }
      ],
      "extract": "Llegar a los grupos diana Probablemente, la edad de administración de las vacunas a los grupos diana que se establecerá en la autorización de comercialización estará comprendida entre los 9 y los 26 años. Ese grupo de edad deberá subdividirse en dos categorías: una prioritaria y otra “de repesca”. Grupo diana prioritario Estará compuesto, muy probablemente, por niñas de 9 a 13 años de edad visto que el objetivo",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-020"
      ]
    },
    {
      "id": "page-021",
      "number": null,
      "title": "Page 21",
      "level": 1,
      "pageStart": 21,
      "pageEnd": 21,
      "labelStart": "16",
      "labelEnd": "16",
      "words": 498,
      "summary": {
        "text": "Continues the discussion of service delivery, in Spanish, noting that staff of youth programmes may lack vaccination skills but that programmes for out-of-school youth can raise awareness and refer young people to vaccination services. It suggests using contacts such as prevention of mother-to-child HIV transmission services to inform women about cervical cancer, HPV vaccines and screening.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "los jóvenes",
          "heading": false
        },
        {
          "term": "vacunación contra",
          "heading": false
        },
        {
          "term": "los servicios",
          "heading": false
        },
        {
          "term": "las mujeres",
          "heading": false
        },
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "los grupos",
          "heading": false
        },
        {
          "term": "cáncer cervicouterino",
          "heading": false
        },
        {
          "term": "programas para",
          "heading": false
        }
      ],
      "extract": "Además, el personal de esos programas puede carecer de las competencias necesarias para prestar servicios de vacunación. No obstante, los programas para jóvenes no escolarizados pueden resultar eﬁ caces para reforzar la sensibilización sobre la inmunización contra el VPH y fomentar el envío de los interesados a servicios de vacunación públicos o privados. También podría estudiarse la creación de nuevos mecanismos de",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-021"
      ]
    },
    {
      "id": "page-022",
      "number": null,
      "title": "Page 22",
      "level": 1,
      "pageStart": 22,
      "pageEnd": 22,
      "labelStart": "17",
      "labelEnd": "17",
      "words": 480,
      "summary": {
        "text": "Stresses, in Spanish, that older women outside the vaccine's age limits still need comprehensive cervical cancer screening, diagnosis and treatment, and that vaccinated girls must also be screened later. It begins discussing the need to plan monitoring and evaluation from the preparatory stage.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "las mujeres",
          "heading": false
        },
        {
          "term": "las vacunas",
          "heading": false
        },
        {
          "term": "será preciso",
          "heading": false
        },
        {
          "term": "que las",
          "heading": false
        },
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "los servicios",
          "heading": false
        },
        {
          "term": "vacunas contra",
          "heading": false
        },
        {
          "term": "alianzas entre",
          "heading": false
        }
      ],
      "extract": "En las autorizaciones de comercialización de las vacunas contra el VPH se establecerán los límites de edad máximo y mínimo de administración a la población diana. Por consiguiente, será preciso asegurarse de que las mujeres de mayor edad cuenten con servicios integrales de detección, diagnóstico y tratamiento del cáncer de cuello uterino que atiendan sus necesidades de cuidado de la salud. Las mujeres y niñas que se",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-022"
      ]
    },
    {
      "id": "page-023",
      "number": null,
      "title": "Page 23",
      "level": 1,
      "pageStart": 23,
      "pageEnd": 23,
      "labelStart": "18",
      "labelEnd": "18",
      "words": 497,
      "summary": {
        "text": "Explains, in Spanish, that effects of the quadrivalent vaccine on genital warts and early lesions will be seen before effects on cervical cancer and that pilot studies may help early evaluation. It lists actions on service delivery, starting with basing strategies on what is feasible and culturally acceptable in each country.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "los efectos",
          "heading": false
        },
        {
          "term": "los datos",
          "heading": false
        },
        {
          "term": "los resultados",
          "heading": false
        },
        {
          "term": "del cáncer",
          "heading": false
        },
        {
          "term": "los países",
          "heading": false
        },
        {
          "term": "los casos",
          "heading": false
        },
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "utilidad para",
          "heading": false
        }
      ],
      "extract": "los programas de inmunización sistemática de los países. Probablemente, antes los efectos (de la vacuna tetravalente) en las verrugas genitales o en las anomalías diagnosticadas mediante la detección – como la neoplasia intraepitelial cervical (NIC) de grado 1 o 2- se observarán que los resultados en el cáncer de cuello de útero. La vigilancia de esos efectos mediante estudios piloto puede resultar de utilidad para",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-023"
      ]
    },
    {
      "id": "page-024",
      "number": null,
      "title": "Page 24",
      "level": 1,
      "pageStart": 24,
      "pageEnd": 24,
      "labelStart": "19",
      "labelEnd": "19",
      "words": 309,
      "summary": {
        "text": "Continues the list of actions, in Spanish, such as extending immunization services to older age groups, aligning messages with cervical cancer, adolescent health and HIV programmes, monitoring vaccine effectiveness, training health workers and defining process and outcome indicators.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "los servicios",
          "heading": false
        },
        {
          "term": "los profesionales",
          "heading": false
        },
        {
          "term": "con los",
          "heading": false
        },
        {
          "term": "del cáncer",
          "heading": false
        },
        {
          "term": "prevención del",
          "heading": false
        },
        {
          "term": "cáncer cervicouterino",
          "heading": false
        },
        {
          "term": "las vacunas",
          "heading": false
        }
      ],
      "extract": "– Ampliar los grupos diana de los servicios del PAI a otros contextos y grupos de mayor edad que los lactantes. – Formular mensajes concordantes con los consejos de las campañas de los programas nacionales de control del cáncer cervicouterino, los servicios de salud salud sexual y reproductiva para adolescentes, y los programas de prevención del VIH, en colaboración con los programas de inmunización basados en las",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-024"
      ]
    },
    {
      "id": "page-025",
      "number": null,
      "title": "Page 25",
      "level": 1,
      "pageStart": 25,
      "pageEnd": 25,
      "labelStart": "20",
      "labelEnd": "20",
      "words": 525,
      "summary": {
        "text": "Discusses, in Spanish, stewardship and financing, giving high priority to mobilizing international and national resources to strengthen health systems and buy HPV vaccines as part of a comprehensive multi-partner strategy. It notes that national decisions should consider benefits not captured in health and cost analyses.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "vacuna contra",
          "heading": false
        },
        {
          "term": "las decisiones",
          "heading": false
        },
        {
          "term": "los gobiernos",
          "heading": false
        },
        {
          "term": "decisiones políticas",
          "heading": false
        },
        {
          "term": "los países",
          "heading": false
        },
        {
          "term": "los contextos",
          "heading": false
        },
        {
          "term": "los análisis",
          "heading": false
        }
      ],
      "extract": "La movilización de recursos para reforzar el sistema de atención de la salud y adquirir vacunas contra el VPH, tanto en el plano internacional, como en los presupuestos de salud de los países, deberá tener una alta prioridad. La ﬁ nanciación de la introducción de la vacunación contra el VPH deberá concebirse como una componente de una estrategia integral en la que participarán distintas partes interesadas, tanto",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-025"
      ]
    },
    {
      "id": "page-026",
      "number": null,
      "title": "Page 26",
      "level": 1,
      "pageStart": 26,
      "pageEnd": 26,
      "labelStart": "21",
      "labelEnd": "21",
      "words": 550,
      "summary": {
        "text": "Stresses, in Spanish, the importance of international funding commitments for HPV vaccines through GAVI, UNICEF and the PAHO Revolving Fund, to encourage manufacturers to expand production capacity and to lower prices. It also covers regulatory tasks after licensing, such as adverse event reporting by the private sector and pharmacovigilance.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "los contextos",
          "heading": false
        },
        {
          "term": "bajos ingresos",
          "heading": false
        },
        {
          "term": "los gobiernos",
          "heading": false
        },
        {
          "term": "los países",
          "heading": false
        },
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "vacunas contra",
          "heading": false
        },
        {
          "term": "ingresos medios",
          "heading": false
        },
        {
          "term": "las vacunas",
          "heading": false
        }
      ],
      "extract": "La obtención de compromisos de ﬁ nanciación internacional para vacunas contra el VPH, por ejemplo a través de la Alianza Mundial para Vacunas e Inmunización (GAVI), el Fondo de las Naciones Unidas para la Infancia (UNICEF) y el Fondo Rotatorio de la Organización Panamericana de la Salud (OPS) es sumamente importante por dos motivos. En primer lugar, decidirá a los fabricantes de vacunas a invertir para aumentar su",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-026"
      ]
    },
    {
      "id": "page-027",
      "number": null,
      "title": "Page 27",
      "level": 1,
      "pageStart": 27,
      "pageEnd": 27,
      "labelStart": "22",
      "labelEnd": "22",
      "words": 358,
      "summary": {
        "text": "Lists, in Spanish, actions on stewardship and financing, such as forming a national working group with broad stakeholder participation to prepare an HPV vaccine introduction strategy and planning for financial sustainability. Countries not eligible for GAVI funding are advised to seek WHO and UNFPA technical help.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "del cáncer",
          "heading": false
        },
        {
          "term": "para los",
          "heading": false
        },
        {
          "term": "los programas",
          "heading": false
        },
        {
          "term": "las repercusiones",
          "heading": false
        },
        {
          "term": "del sector",
          "heading": false
        },
        {
          "term": "relación con",
          "heading": false
        },
        {
          "term": "cada país",
          "heading": false
        },
        {
          "term": "así como",
          "heading": false
        }
      ],
      "extract": "de prospectos con mensajes adecuados tanto para los encargados de la vacunación, como para los pacientes. Actividades En relación con la rectoría y ﬁ nanciación, será preciso emprender las siguientes actividades: • Prepara una estrategia para la introducción integral y viable de las vacunas contra el VPH, que debería contar con la participación de una amplia serie de partes interesadas. En cada país debería crearse",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-027"
      ]
    },
    {
      "id": "page-028",
      "number": null,
      "title": "Page 28",
      "level": 1,
      "pageStart": 28,
      "pageEnd": 28,
      "labelStart": "23",
      "labelEnd": "23",
      "words": 418,
      "summary": {
        "text": "Concludes, in Spanish, that the decision on whether and when to introduce HPV vaccination rests with national policies and that effective alliances are needed because the vaccines span several programmes. It ends with a note on the conditions for which the quadrivalent vaccine was licensed by the US FDA.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "neoplasia intraepitelial",
          "heading": false
        },
        {
          "term": "intraepitelial cervical",
          "heading": false
        },
        {
          "term": "vacunación contra",
          "heading": false
        },
        {
          "term": "será preciso",
          "heading": false
        },
        {
          "term": "prevenir las",
          "heading": false
        },
        {
          "term": "del acceso",
          "heading": false
        },
        {
          "term": "nuevas vacunas",
          "heading": false
        },
        {
          "term": "las siguientes",
          "heading": false
        }
      ],
      "extract": "En última instancia, la decisión relativa a la introducción de la vacunación contra el VPH, así como a la fecha en que se hará, dependerán de las políticas nacionales de cada país. La importancia que se concederá a la vacuna contra el VPH dentro de una estructura global e integrada de vacunación constituye una consideración general. Puesto que estas vacunas “corresponden” a varios programas diferentes, el",
      "extractCut": true,
      "blocks": [
        "library/10665-69654/blocks/prose-page-028"
      ]
    },
    {
      "id": "page-029",
      "number": null,
      "title": "Page 29",
      "level": 1,
      "pageStart": 29,
      "pageEnd": 29,
      "labelStart": "24",
      "labelEnd": "24",
      "words": 13,
      "summary": {
        "text": "Lists, in Spanish, additional resources, with website links for UNFPA, WHO, the Global Immunization Vision and Strategy and GAVI.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Recursos adicionales UNFPA http://www.unfpa.org/ OMS http://www.who.int/es/ http://www.who.int/reproductive-health http://www.who.int/cancer/en/ http://www.who.int/reproductive-health/pages_resources/listing_cancer.en.html GIVS http://www.who.int/immunization/givs/en/index.html GAVI http://www.gavialliance.org/",
      "extractCut": false,
      "blocks": [
        "library/10665-69654/blocks/prose-page-029"
      ]
    },
    {
      "id": "page-030",
      "number": null,
      "title": "Page 30",
      "level": 1,
      "pageStart": 30,
      "pageEnd": 30,
      "labelStart": "Sec2:25",
      "labelEnd": "Sec2:25",
      "words": 5,
      "summary": {
        "text": "A page with no extracted text.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "_(no text on this page)_",
      "extractCut": false,
      "blocks": [
        "library/10665-69654/blocks/prose-page-030"
      ]
    }
  ],
  "checks": {
    "tocAlignment": {
      "listed_not_found": {
        "count": 0,
        "items": []
      },
      "found_not_listed": {
        "count": 0,
        "items": []
      },
      "page_mismatch": {
        "count": 12,
        "items": [
          "Grupos diana de la inmunización contra el VPH: listed p23, found p21",
          "Aspectos inhabituales de las vacunas contra el VPH: listed p23, found p11",
          "Una oportunidad única: listed p23, found p11",
          "Un producto oneroso: listed p23, found p14",
          "Problemática de la introducción: listed p23, found p15",
          "Nuevas formas de colaboración: listed p23, found p15",
          "Sensibilización, información y comunicación: listed p23, found p16",
          "Prestación de servicios: listed p23, found p20",
          "Llegar a los grupos diana: listed p23, found p20",
          "Rectoría y ﬁ nanciación: listed p23, found p25",
          "Conclusión: listed p23, found p28",
          "Recursos adicionales: listed p23, found p29"
        ]
      }
    },
    "figureSequenceGaps": [],
    "pageLabelConflicts": {
      "count": 27,
      "items": [
        "p3: pdf-labels III, printed ii",
        "p4: pdf-labels IV, printed iii",
        "p5: pdf-labels Sec1:4, printed iv",
        "p6: pdf-labels Sec2:1, printed 1, contents 1",
        "p7: pdf-labels Sec2:2, printed 2",
        "p8: pdf-labels Sec2:3, printed 3, contents 3",
        "p9: pdf-labels Sec2:4, printed 4",
        "p10: pdf-labels Sec2:5, printed 5",
        "p11: pdf-labels Sec2:6, printed 6",
        "p12: pdf-labels Sec2:7, printed 7",
        "p13: pdf-labels Sec2:8, printed 8",
        "p14: pdf-labels Sec2:9, printed 9",
        "p15: pdf-labels Sec2:10, printed 10",
        "p16: pdf-labels Sec2:11, printed 11",
        "p17: pdf-labels Sec2:12, printed 12",
        "p18: pdf-labels Sec2:13, printed 13",
        "p19: pdf-labels Sec2:14, printed 14",
        "p20: pdf-labels Sec2:15, printed 15",
        "p21: pdf-labels Sec2:16, printed 16",
        "p22: pdf-labels Sec2:17, printed 17",
        "p23: pdf-labels Sec2:18, printed 18, contents xx",
        "p24: pdf-labels Sec2:19, printed 19",
        "p25: pdf-labels Sec2:20, printed 20",
        "p26: pdf-labels Sec2:21, printed 21",
        "p27: pdf-labels Sec2:22, printed 22",
        "p28: pdf-labels Sec2:23, printed 23",
        "p29: pdf-labels Sec2:24, printed 24"
      ]
    }
  },
  "withheld": false,
  "keywords": [
    {
      "term": "vph los",
      "heading": false
    },
    {
      "term": "vph las",
      "heading": false
    },
    {
      "term": "contra los",
      "heading": false
    },
    {
      "term": "vacunas los",
      "heading": false
    },
    {
      "term": "los que",
      "heading": false
    },
    {
      "term": "del vph",
      "heading": false
    },
    {
      "term": "para los",
      "heading": false
    },
    {
      "term": "los programas",
      "heading": false
    },
    {
      "term": "por los",
      "heading": false
    },
    {
      "term": "salud los",
      "heading": false
    },
    {
      "term": "vacunación contra",
      "heading": false
    },
    {
      "term": "con los",
      "heading": false
    }
  ],
  "pageLabels": [
    {
      "physical": 1,
      "label": "I",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 2,
      "label": "II",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 3,
      "label": "ii",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 4,
      "label": "iii",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 5,
      "label": "iv",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 6,
      "label": "1",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 7,
      "label": "2",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 8,
      "label": "3",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 9,
      "label": "4",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 10,
      "label": "5",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 11,
      "label": "6",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 12,
      "label": "7",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 13,
      "label": "8",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 14,
      "label": "9",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 15,
      "label": "10",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 16,
      "label": "11",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 17,
      "label": "12",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 18,
      "label": "13",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 19,
      "label": "14",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 20,
      "label": "15",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 21,
      "label": "16",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 22,
      "label": "17",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 23,
      "label": "18",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 24,
      "label": "19",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 25,
      "label": "20",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 26,
      "label": "21",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 27,
      "label": "22",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 28,
      "label": "23",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 29,
      "label": "24",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 30,
      "label": "Sec2:25",
      "source": "pdf-labels",
      "confidence": 0.7
    }
  ],
  "figures": [],
  "coverage": [
    {
      "kind": "contents",
      "state": "not-extracted",
      "note": "split one section per page; no contents was trusted"
    },
    {
      "kind": "sections",
      "state": "partial",
      "count": 30,
      "note": "one per page, not by heading"
    },
    {
      "kind": "figures",
      "state": "none"
    },
    {
      "kind": "tables",
      "state": "not-extracted"
    },
    {
      "kind": "references",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "glossary",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "footnotes",
      "state": "not-extracted"
    },
    {
      "kind": "summaries",
      "state": "found",
      "count": 30,
      "note": "30 of 30 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/10665-69654"
  }
}
